MAL2 and hepatocellular carcinoma: Activation of the PI3K/AKT signaling pathways to sustain HCC cellular proliferation and survival was also confirmed by Western blot analyses in IL7 and MAL2-overexpressing PLC/PRF/5 cells (Figure 3B).